SIU Academy is a digital learning resource for urologists
Enter the portal

SIU Academy Governance 

 

Stavros Gravas

Stavros Gravas

MD, PHD, FEBU - Greece

Dr. Stavros Gravas became a qualified urologist in 1999 and was also qualified as Fellow of the European Board of Urology (FEBU) in the same year. In 2002, he attended the 12-month fellowship on Endourology (by the Endourological Society) at Minimal Invasive Urology Centre and Laparoscopy of the University Hospital in Nijmegen. In 2005, he received his doctorate degree from the University of Athens, and in 2007 his Ph.D. thesis entitled “Transurethral Microwave Thermotherapy for BPH – From Evidence-based Guidelines to Clinical Practice” from the University of Amsterdam. 

Dr. Gravas is the chairman of the European Association of Urology (EAU) Guidelines Working Group on BPH/male LUTS/BOO. He was member of the Committee on New Minimally Invasive and Surgical Developments in the management of Benign Prostatic Obstruction of the International Consultation on Prostate Diseases. Other working group memberships include the Editorial Board at Large of European Urology and European Urology Supplements, the Editorial Board of Journal of Endourology (serving as Section Editor on New Technologies). 

Dr. Gravas is a member of the Council of the Clinical Research Office of the Endourological Society (CROES) representing Europe and he served as member of the Board of the Directors of the Endourological Society until 2012. He is a member of many national and international societies and reviewer in European Urology, Journal of Urology, Urology, British Journal of Urology International, Journal of Endourology, International Journal of Urology, Current Urology, Clinical Drug Investigation and Hellenic Urology. 

Dr. Gravas is Assistant Professor of Urology (University of Thessalia) and works at the Department of Urology of the University Hospital of Larissa. His main fields of interest include medical and minimally invasive therapies for BPH, endourology, and stone management.

Kurt McCammon

Kurt McCammon

MD, FACS - United States

Dr. McCammon earned his medical degree, magna cum laude, from the Medical College of Ohio in Toledo, OH, in 1992 after completing his undergraduate degree in Biology at the University of Toledo in 1988. He served his internship in general surgery in the Department of Surgery at Eastern Virginia Graduate School of Medicine, where he also completed his residencies in general surgery and urology, receiving the Upjohn Award for Intern of the Year in 1993 and Eunice Baxter award for Chief Resident of the Year in 1997.  He completed a Fellowship in Adult and Pediatric Genitourinary Reconstructive Surgery at Eastern Virginia Medical School in 1998.

Dr. McCammon’s practice is limited almost exclusively to adult and pediatric genitourinary reconstructive surgery.  Board certified in Urology, he is a Fellow of the American College of Surgeons.  Dr. McCammon serves as Professor of Urology at Eastern Virginia Medical School and currently serves as the Chairman and Program Director of the Department of Urology and is the Director of the Adult and Pediatric Genitourinary Reconstructive Fellowship Program at the Eastern Virginia Medical School.  He was honored to be named the Devine Chair in Genitourinary Reconstructive Surgery in 2013.  He has wide and varied academic interests and is an innovative leader in the field of genitourinary reconstructive surgery.  He is keenly motivated in the area of investigation and has made notable contributions to Urologic literature.  Dr. McCammon also participates in numerous national and international medical conferences and serves as a visiting professor at many centers throughout the world.

SIU Academy Governance Committee

Peter Black

Peter Black

MD, FACS, FRCSC - Canada

Dr. Peter Black is a Urologic Oncologist at Vancouver General Hospital, a Research Scientist at the Vancouver Prostate Centre, and an Associate Professor in the Department of Urologic Sciences at the University of British Columbia (UBC). He received his undergraduate degree from the UBC and his medical degree from Johannes Gutenberg University in Mainz, Germany. He completed his urologic training at the University of Washington in Seattle and fellowship in urologic oncology at M.D. Anderson Cancer Center in Houston, Texas.  He has a clinical subspecialty interest in bladder cancer and a translational research program in urothelial carcinoma. This research focuses on the integration of advanced biomarkers and novel targeted therapies to promote precision oncology and is supported by peer-reviewed grant funding. He is actively involved in the design and conduct of clinical trials in genitourinary cancers. Dr. Black has 130 publications in both clinical and translational research domains. He is on the editorial board of six journals and reviews regularly for 24 journals. He participated in the 2014-15 American Urological Association Leadership Program and sits on the Board of Directors of the Société Internationale d’Urologie.

Jean de la Rosette

Jean de la Rosette

MD - Turkey

Dr de la Rosette is Professor in Urology at Amsterdam UMC University Hospital in Amsterdam (the Netherlands) and Professor in Urology at Istanbul Medipol University, Istanbul (Turkey). He completed his medical degree and urology residency at St Radboud University Hospital in Nijmegen, the Netherlands. His main fields of interest are minimal invasive surgery and endourology with a special focus on ablative treatments and urological ultrasound. Dr de la Rosette is a member of the committee on Minimal Invasive Treatment of Benign Prostatic Hyperplasia (BPH) and the committee on Upper Urinary Tract Urothelial tumors of the ICUD. He is also co-chairman of the committee on Renal Stone Disease of the ICUD. He is past-chairman of the EAU Section of Uro-Technology (ESUT) and board member of the Society of Endourology. Dr. de la Rosette was a chairman of the European Association of Urology (EAU) working party on BPH guidelines. Dr de la Rosette is (co)author of over 700 peer-reviewed publications and has authored many book chapters. Dr de la Rosette is a member of various urological societies and board member of the Endourological Society and the Société International d’Urologie (SIU). Since 2016 he holds the position of General Secretary of the SIU.

Reynaldo G. Gomez

Reynaldo G. Gomez

MD, FACS - Chile

Dr Reynaldo Gómez obtained his MD degree from the Catholic University of Chile School of Medicine in 1978. He then completed a residency program in general surgery and urology, obtaining a Master of Surgery degree and a Specialist in Urology degree in 1984 from the same school. He completed his training with a postdoctoral fellowship at the University of California, San Francisco School of Medicine, and the San Francisco General Hospital in 1991.

Dr Gómez started the Urology Service at the Hospital del Trabajador in Santiago, Chile, in 1984, and has been its chief since then. He was appointed associate professor of urology at the Andrés Bello University School of Medicine in 2011.

Dr Gómez is a member of many scientific societies and was president of the Chilean Society of Urology in 2001–2002. He has served on the Board of the Confederacion Americana de Urologia and was president of the Genitourinary Reconstructive Surgeons Society (GURS) in 2010. Dr Gómez is a reviewer on the editorial boards of the Chilean Journal of Surgery, the Chilean Journal of Urology, Urology (the Gold Journal), and the International Urology and Nephrology Journal.

Dr Gómez has been involved with the SIU since 2000, serving as the Chilean delegate from 2001 to 2010. He served in the SIU BOC from 2004 to 2011, as chairman of the Publications Committee and then as chair of the Internet and Telecommunications Committee. 

Simon Tanguay

Simon Tanguay

MD, FRCSC - Canada

Dr Tanguay completed his residency training at McGill University in 1992 and his fellowship in urologic oncology at the University of Texas M. D. Anderson Cancer Center in 1995.  He is currently Professor and Chairman of the Division of Urology at McGill University and the M. Elhilali and D. Azrieli Chair in urologic sciences.

Dr Tanguay was actively involved in the Quebec Urological Association where he served as president of the Continuing Medical Education committee from 2001 to 2004 and served as treasurer of this association.  He was Co-Director of the clinical research unit within the Division of Urology at McGill University.

Dr Tanguay served as member of the executive committee of the Genito-Urinary group at the National Cancer Institute of Canada and as the Chair of the Canadian Kidney Cancer Information System from 2009 to 2016.  He was the General Secretary of the Société Internationale d’Urologie from 2011 to 2016 and now serves as President Elect.

Faysal Yafi

Faysal Yafi

MD, FRCSC - United States

Dr. Yafi earned his medical degree from the American University of Beirut, Lebanon in 2005 after completing his undergraduate degree in Biology at the same institution in 2001. He then served his internship in General Surgery in the Department of Surgery at the American University of Beirut in 2006 before transferring to the Mayo Clinic in Rochester, Minnesota where he completed a year of preliminary surgery in the Department of Surgery in 2007. He subsequently completed a two-year research fellowship in the Biology and Therapy of Bladder Cancer in the Division of Urology at McGill University in Montreal, Canada in 2009. He subsequently completed his residency in Urology at McGill University in 2014, receiving the Division of Urology Outstanding Resident/Fellow Teacher of the Year Award in 2014. He is currently in the second year of his fellowship in Andrology at Tulane University, where he also serves as Clinical Instructor of Urology.

Dr. Yafi is a Fellow of the Royal College of Surgeons of Canada (Urology). He has previously served as chairman of the Northeastern Section of the AUA Residents Committee and member of the AUA Residents Committee. He is currently a member of the Sexual Medicine Society of North America Young Clinicians Committee. He has received multiple awards and recognitions, including the first prize essay contest of the Canadian Urological Association. Dr. Yafi has an avid interest in both basic and clinical research, with over 40 peer-reviewed publications and book chapters. His areas of focus include Peyronie’s disease, erectile dysfunction, androgen replacement therapy, prosthetic surgery (inflatable penile prosthesis and artificial urinary sphincter), male infertility, and urethral reconstruction.

Jack Zuckerman

Jack Zuckerman

MD - United States

Dr. Zuckerman attended medical school at Wake Forest University School of Medicine.  He completed an internship in General Surgery at the Naval Medical Center in San Diego and then went on to complete Urology residency at Eastern Virginia Medical School in Norfolk, Virginia.  He finished his training at EVMS with a fellowship in genitourinary reconstructive surgery.  He recently returned to California and is faculty at the Naval Medical Center in San Diego.

Dr. Zuckerman’s research interests are primarily focused on male reconstruction, including ongoing prospective randomized controlled trials, basic science animal models and large clinical databases.  While his focus is on urologic reconstruction he has published on a variety of other urologic topics, including oncology and general urology.

SIU Academy Education Council

Guosheng Yang

Guosheng Yang

MD, PhD - China

Dr. Guosheng Yang is Director of Urology at the Heyuan Hospital Branch of Guangdong Second Provincial General Hospital. Previously, he was Associate Chief Physician within the Department of Urology, at the First Affiliated Hospital, Zhejiang University, School of Medicine, Hangzhou, China.

Dr. Yang received his medical degree specializing in urology from Wannan Medical College in Wuhu, China. He earned his doctoral degree in Urology from Zhejiang University School of Medicine in Hangzhou, China. He completed a postdoctoral research fellowship at the Department of Pathology, the George Whipple Laboratory of Cancer Research at the University of Rochester Medical Center in New York, USA.

He has published numerous articles in international journals. He is associated with a number of professional associations in various capacities including Secretary-General of the Urological committee of Capacity Building and Continuing Education, National Health and Family Planning Commission; Vice Secretary-General of Chinese Urology and Andrology Innovation; Vice Secretary-General of the Urological and Andrological Association of China Association for Medical Devices Industry; Member of the Committee of International Alliance of Urolithiasis (IAU); Member of the Calculus Committee of CUA; Vice Chairman of the Urological Association, Guangdong Medical Association; and Chairman of the Laser Research Team of the Urological Association, Guangdong Medical Association.

Mohsen Elmekresh

Mohsen Elmekresh

MD - United Arab Emirates

Dr. Mohsen Mohamed El-Mekresh is Consultant and Chief Urologist, and Chair of the Surgery Department, at Mafraq Hospital, Abu Dhabi, UAE where he founded a state-of-the-art Urology Center.                                                   

His surgical expertise is within pediatric urology, adult urology, endourology, reconstructive and oncologic surgery including urinary diversion, and cadaveric and living donor kidney transplantation.

Dr. El-Mekresh earned his Bachelor of Medicine, Bachelor of Surgery degree from Mansoura University. He then completed residencies in Urology and Surgery. He went on to obtain his Master of Science degree and medical degree from Mansoura University. He is a Fellow of the American College of Surgeons and certified by the German Board of Urology.

At Mafraq Hospital Dr. El-Mekresh is Chair of the Morbidity and Mortality Committee and Chair of the OR Committee; he is a member of the Patient Safety and Quality Committee, the Medical Executive Committee, the Pharmaceutical and Therapeutic Committee, and the Leadership Council. He is a member of the Urology and Nephrology Council of Abu Dhabi Health service (SEHA) and Chair of the SEHA service line Urology Council.

Dr. El-Mekresh is a reviewer for the journal Urology Annals, Surgery Research and Practice, Clinical Genitourinary Cancer, Sultan Qaboos University Medical Journal and Journal of Pediatrics & Neonatal Care. He has co-authored over 50 articles, presented more than 100 papers at conferences and has participated in more than 90 scientific meetings and conferences. He is the recipient of many awards including the Emirates Urologic Society (EUS) Scientific Award (2016).

He is a member of numerous professional associations and societies including the Egyptian Medical Syndicate, the Egyptian Urological Association, the European Urological Association, the American Urological Association, the European Society for Organ transplantation and Société Internationale d'Urologie (SIU).

Julian Struck

Julian Struck

MD - Germany

Dr. Julian Struck is currently an Assistant Physician in urology at the University Hospital of Luebeck, Germany. 

Dr. Struck received his medical degree from the University of Cologne‘s Faculty of medecine in Germany followed by his doctoral degree in medicine. He completed residencies in Urology at University Hospital of Luebeck and Hospital Maria Hilf GmbH in Germany. Dr. Struck also studied within the department of Urology at University Hospital Lille (CHRU), Lille, France.

He earned DEGUM certificates for abdominal, urologic and transvaginal ultrasound, as well as DGU certificates for semen analysis, urine cytology and urodynamics.

Dr. Struck has volunteered his time as Chairman and board member (treasurer) of the German Society for Residents in Urology (GeSRU) e.V. He completed basic military training in the German army.

Petros Sountoulidis

Petros Sountoulidis

MD, PhD, FEBU - Greece

Dr. Petros Sountoulidis is a consultant urologist in the Urology Department of Veria General Hospital in Greece and the acting Chief of the 12-bed Urology Department, overseeing three specialists and two urology residents.

His responsibilities include the care of inpatients and performing surgical urological procedures including endourological and BPH procedures (open prostatectomy, TURP, GreenLight laser), TURBT for bladder tumors, ureteroscopy (flexible and rigid) and nephrectomy. He is trained in laparoscopy and robotic surgery (certified console surgeon for the da Vinci system). Other responsibilities include resident training, the supervision of clinical trials within the department and trials in collaboration with other urological departments and colleagues in Europe.

Dr. Sountoulidis received his medical degree from Aristotle University of Medicine in Thessaloniki in 1996. He then completed his residency training and qualified as a urologist in Greece. The same year he was named a Fellow of the European Board of Urology (FEBU) after successfully passing the FEBU examinations. He was awarded a doctoral degree (with honors) from the Medical School of Ioannina, Greece, in May 2010.

He is a member of several scientific societies including the American Urological Association (AUA), the European Association of Urology (EAU), the Endourological Society, the International continence society (ICS) and the Société Internationale
d’Urologie (SIU). He has served as a reviewer for a number of peer-reviewed medical journals. He is currently acting as Associate Editor for Archivos Espanoles de Urologia, the Journal of Medical Case Reports, BMC Research Notes, and Journal of Pakistan Medical Students.

Belinda F. Morrison

Belinda F. Morrison

MB BS, (Hons), DM (Urol) - Jamaica

Dr. Belinda Morrison is a Consultant Urologist at the Department of Surgery, Radiology, Anaesthesia and Intensive Care, at the University of the West Indies, Faculty of Medical Sciences in Jamaica. She is a senior lecturer in surgery at the Mona Institute of Medical Sciences, University Hospital of the West Indies.

Dr. Morrison received her medical degree (with honors) from the University of the West Indies, Faculty of Medical Sciences. She earned a doctorate in Medicine from the same institution and is currently a PhD candidate in Epidemiology at the Tropical Metabolism Research Institute, University Hospital of the West Indies.

She is a member of numerous learned societies including the Jamaica Urological Society (JUS), the American Urological Association (AUA), the European Association of Urology (EAU), the Association of Surgeons of Jamaica, the Medical Association of Jamaica, the Sexual Medicine Society of North America, African-Caribbean Cancer Consortium (AC3), the Prostate Cancer Transatlantic Consortium (CaPTC), the Caribbean Urological Association and Société Internationale d’Urologie.

Dr. Morrison has received many honors and rewards including the MBBS Valedictorian Graduating Class of 2000 (2000), the Prime Minister’s Award for Academic excellence (2001), Commonwealth Scholarship (2005), JUS Prize for Annual Research Day presentation in Urology (2008), American Urological Association – Best Poster Prize in Andrology (2011), Principal’s Award for Research – University of the West Indies (2014), and the American Urological Association – Best Poster Prize in Prostate Cancer.

She completed several research studies as Principal Investigator and is currently involved in studies as Principal Investigator and Co-Investigator. She has published several book chapters, more than 50 journal articles and abstracts, and presented more than 60 papers and posters at scientific meetings as an invited speaker. She is also a regular participant in media and other public service activities.

Masatoshi Eto

Masatoshi Eto

MD - Japan

Dr. Masatoshi Eto is Professor and Chairman of the Department of Urology at the Graduate School of Medical Sciences, Kyushu University in Japan.

Dr. Eto’s focus and research field of interest is on the diagnosis and treatment of urological cancers, tumor immunology and urologic surgery (including laparoscopic and robotic surgery).

Dr. Eto received his medical degree from the Faculty of Medicine at Kyushu University and then completed his residency and clinical fellowship in Urology at the same institution. He was awarded his doctoral degree from the Department of Immunology, Medical Institute of Bioregulation, Kyushu University.

He is a member of numerous academic societies including the Japanese Urological Association, the Japanese Cancer association, the Japan Society of Clinical Oncology, the Japanese Association for Transplantation, the Japanese Society of Immunology, the Japan Society for Endoscopic Surgery, the Japanese Society of Endourology and ESWL, the American Urological Association, the European Association of Urology, the American Society of Clinical Oncology and The Transplantation Society.

Dr. Eto is the recipient of several awards including the 94th JUA Annual Meeting Award (2006), the 49th JSCO Best Oral Presentation Award (2011), the 27th Annual EAU Congress Best Poster Award (2012), the Best Reviewer Award for a grant-in-aid for scientific research of JSPS Japan Society for the Promotion of Science (JSPS) (2012) and the 22nd JUA Award (2015). He has co-authored more than 150 journal articles.

James Ikol

James Ikol

MD - Kenya

Dr. Ikol James Adung’o is a Consultant Urologist at Kenyatta National Hospital in Kenya. His previous position was Lecturer within the Department of Human Anatomy at Kenyatta University School of Medicine.

Dr. Adung’o is a general and urologic surgeon with research interests in genitourinary tumours.

He earned his Bachelor of Medicine and Bachelor of Surgery degree from the University of Nairobi and a Master of Medicine in General Surgery from the same institution. He completed a fellowship in Urology at KCMC in Moshi, Tanzania. He is board-certified by the Kenya Medical Practitioners and Dentist’s Board (KMP&DB) as a General Medical Practitioner, a Medical Specialist and Urology Specialist.

Dr. Adung’o is a member of several professional societies and associations including Kenya Association of Urological Surgeons, the Surgical Society of Kenya, Kenya Medical Association, Association of Surgeons of East Africa,   Kenya Catholic Doctors Association and Société Internationale D'Urologie (SIU).

He has published several articles in scientific journals, presents at and attends conferences, workshops and seminars.  Dr. Adung’o is a member of the KAUS conference organizing committee and of the Editorial Board of the East & Central Africa Medical Journal.

Soodong Kim

Soodong Kim

MD, PhD - Republic of Korea

Dr. Soo Dong Kim is a urologist within the Department of Urology at Dong-A University Medical Center in Busan, Korea. He specializes in urologic cancer, other urologic tumors, andrology, sexual dysfunction, prostate disease, laparoscopic surgery and robotic surgery.

Dr. Kim earned his medical degree from Dong-A University, College of Medicine, and then continued his education, completing a master’s degree followed by his doctorate at the same institution.

Past positions include Assistant Professor and Instructor within the Department of Urology at the College of Medicine in Busan, Korea. Dr. Kim is a certified clinical trial investigator and has participated as co-investigator in numerous clinical trials including those focused on various therapies and urologic oncology.

Poongkodi Nagappan

Poongkodi Nagappan

MD, FRCS (Urol) - Malaysia

Dr. Poongkodi Nagappan is a Consultant Urologist within the department of Urology at Selayang Hospital, Selangor, Malaysia. Her areas of clinical interests are paediatric and reconstructive urology and renal cancer.

Dr. Nagappan graduated from the University Malaya in 1999, completed her surgical and urological training in Malaysia, and then attended Royal Manchester Children’s Hospital in England to continue her training in paediatric urology. Returning to Malaysia, and with the aid of paediatric nephrology colleagues, Dr. Nagappan expanded paediatric urology service to the northern part of the state of Selangor.

Dr. Nagappan is a Fellow of the Royal College of Physicians and Surgeons of Glasgow and Honorary Secretary of the Malaysian Urological Association. She is board-certified in Urology. She is a member of several professional organizations including the Society of Women in Urology, and is a life member of the Malaysian Urological Association and Malaysian Medical Association.

She is the recipient of many awards and prizes including the 2017 Excellent Service Award from the Ministry of Health Malaysia (Selayang Hospital), the 2014 Paediatric Urology Trophy for best registrar presentation at the British Association of Paediatric Urologists Congress and the 2014 British Association of Paediatric Endoscopic Surgeons Prize for best abstract presented at the annual scientific meeting.

Dr. Nagappan is involved in several paediatric research trials. She has authored numerous articles and peer-reviewed papers, organizes course curriculums, and as a faculty member, is engaged in lectures and conferences both on national and international levels.

Sultan Alkhateeb

Sultan Alkhateeb

MD - Saudi arabia

Coming Soon

John Lazarus

John Lazarus

MD - South Africa

Dr. John Michael Lazarus is Head of the Urology Department at University of Cape Town, Cape Town Area in South Africa.

Dr. Lazarus earned his medical degree from University of Cape Town followed by a postgraduate diploma in African Studies at the same institution. He completed a Master of Arts degree in Documentary Film at the University of London. Returning to the University of Cape Town, Dr. Lazarus completed a fellowship and then earned a Master of Medicine degree.

He is the recipient of many awards and prizes including the Karl Storz & Marcus Medical postgraduate merit award from the South African Urological Association (2006), an award that recognises research and surgical innovation; the Phillip Smith prize for best UCT postgraduate student in urology (May 2007); the Medical Research Council (MRC) Medical Devices Award (2012) for South African Circumcision Device; Sanofi Award at the 2014 SAUA congress for outstanding contribution to SA urology, and Kind Cuts for Kids (June 2017), an award for surgical outreach.

Dr. Lazarus has patented two devices: the AirScope, a novel wireless laparoscope and the Locator, a percutaneous renal surgery navigation system. He is involved with international commercial and non-commercial clinical trials as Co-Investigator and Principal Investigator.

He is an editorial board member of the Journal of African Urology and Advances in Urology. He is a reviewer for the Journal of Paediatric Surgery, Annals of Pediatric Surgery, and the World Journal of Urology (SIU journal). Dr. Lazarus attends numerous workshops and conferences as both an invited speaker and a participant.

Shing-Hwa Lu

Shing-Hwa Lu

MD, PhD - Taiwan

Prof. Shing-Hwa Lu is professor of Urology at the School of Medicine at National Yang-Ming University, and Division Chief of the Department of Urology at Taipei Veterans General Hospital, Taipei, Taiwan.

Prof. Lu is focused on stem cell research and regenerative medicine as it relates to voiding dysfunction. He also has expertise in minimally invasive surgery, including robot assisted laparoscopic surgery, having completed the necessary training at the IRCAD Laparoscopic Training Center in Strasbourg, France. He is on the faculty of IRCAD Laparoscopic Training Center, Asia.

Prof. Lu received his doctoral degree from the department of Biochemistry at National Yang-Ming University. He completed a postdoctoral fellowship in the Department of Pharmacology and Stem Cell Research Center at the School of Medicine, University of Pittsburgh School of Medicine, USA. (Under the supervision of Profs. William Chet de Groat and Michael B. Chancellor.)

He is the recipient of many international awards including first prize for an essay from SUFU (Society of Urodynamics Female Urology), second prize for an essay from the AUA (American Urological Association) and first prize from Archimedes International Salon of Inventions and Innovation Technologies.

Prof. Lu has published more than 85 peer-reviewed scientific papers. He is a council member of the Asian Pacific Prostate Society (APPS) and the Deputy Editor-in-Chief of Formosan Journal of Surgery, the official journal of the Taiwan Surgical Association. He the president of Taiwan Health and Welfare Society and is a council member of the Chinese Innovation and Invention Society.

He is past President of the Asian Society for Female Urology, past Vice president of the Taiwan Continence Society, past Chairman of the committee of Urodynamics and Female Urology in Taiwan Urological Association. He was the council member of the Pan-Pacific Continence Society. He holds several leadership appointments in professional associations and committees associated with urology, invention and innovation.

 

Guven Aslan

Guven Aslan

MD - Turkey

Prof. Dr. Guven Aslan is currently Professor of Urology in the urology department at the Dokuz Eylul University School of Medicine in Turkey. He joined the university as Instructor of Urology, then held the position of Assistant Professor, followed by Associate Professor.

Dr. Aslan completed his residencies in Urology at Ankara State Hospital and Dokuz Eylul University in Turkey. He is board-certified.

In addition to lecturing within his department, he is responsible for continuing education for urologists, and clinical instruction and supervision of residents within the urology department. He is active in clinical reseach with a strong focus on urologic cancers; diagnosis, therapy and surgery.

At intervals he is a visiting physician to University of Southern California (USC) Norris Comprehensive Cancer Center, Los Angeles, Chaim Sheba Medical Center, Israel and Urological Research Institute Vita Salute San Raffaele University, Italy. 

Dr. Aslan is Secretary General of the Uro-oncology Association of Turkey. He is a member of several professional associations including the Urologic Surgery Association (Turkey), Minimally Invasive Urology Association (Turkey) and the European Association of Urology (EAU).

Dr. Aslan is the recipient of the 2003 Cardura Competitive Awards and the 2005

Alpay Kelami Award for Male Sexual Health Research. Has co-authored more than 50 articles and is a reviewer for several journals including Urology, Journal of Advances in Medicine and Medical Research and Asian Journal of Andrology.

Sub-committees

Bladder and Upper Urinary Tract TCC

Rafael Sanchez-Salas

Rafael Sanchez-Salas

MD - France

Dr. Rafael Sanchez-Salas is a urological surgeon at the Institut Mutualiste Montsouris in Paris, France.  He received his medical degree from the Universidad de los Andes (ULA) in Mérida, Venezuela, followed by general surgery and urological training at the Hospital Universitario de Caracas, also in Venezuela.

After basic training, Dr. Sanchez-Salas undertook research and clinical fellowship training in urological oncology and minimally invasive urological surgery at Memorial Sloan-Kettering Cancer Center in the United States, Clínica Santa María in Chile, and the Institut Mutualiste Montsouris in France, where he eventually earned his spot as staff surgeon.

In addition to surgical work, Dr. Sanchez-Salas is an active academic urologist with international publications and ongoing collaborations in the field of urological oncology and minimally invasive surgery. He runs the Medical Education Office for the Confederación Americana de Urología (CAU), and he has recently been inducted to the Board of the European Robotic Urological Society (ERUS).

François Audenet

François Audenet

MD - France

Dr Francois Audenet is assistant professor in the Department of Urology at Hôpital Européen Georges-Pompidou in Paris, France.

Dr Audenet received his medical degree in Paris from Sorbonne Université – Faculté de Médecine Pierre et Marie Curie and completed his education with residencies in General Surgery and Urology at Paris University Hospitals.

After obtaining a research master’s degree in Surgical Science (2011) and completing surgical training in 2012, he was granted  the Gold Medal in Surgery, awarded each year to the best resident enrolled in the surgical program of Paris University Hospitals. He then completed  fellowship training in minimally invasive surgery and Urologic Oncology at Institut Mutualiste Montsouris in Paris, followed by a Urologic Oncology Fellowship at the David Solit Lab, Memorial Sloan Kettering Cancer Center in New York, USA.

Dr Audenet is dedicated to urological oncology and minimally invasive surgical techniques, and is engaged in research and teaching duties at his institution. He has published more than 75 peer-reviewed research papers and he reviews paper submissions for several urological journals. His research is primarily focused on oncology, particularly oncogenetics in urothelial carcinoma.

Alexandre Ingels

Alexandre Ingels

MD - France

Dr. Alexandre Ingels is a urologist and senior surgeon in the Department of Urology at the Institut Mutualiste Montsouris in Paris. His main area of interest is uro-oncology, and more specifically, renal cell carcinoma. Dr. Ingels is currently a PhD candidate at Paris Sud University, working on molecular imaging in renal cell carcinoma at the Institut Gustave Roussy laboratory.

Dr. Ingels completed basic training at the University Hospital System of Paris and post-doctoral training in basic research at Stanford University, California. He continued as a fellow in uro-oncology at AMC, Amsterdam, followed by two years as Assistant Professor at Kremlin-Bicêtre Hospital in France, focusing on uro-oncology and transplantation.

He earned his master’s degree in Public Health (2010) and a Master of Science in biology (2012) with a focus on renal cell carcinoma, participating in the development of an in-vivo model of renal cell carcinoma and its development for pre-clinical drug explorations.

As a clinician, he developed an expertise in major uro-oncology surgeries for renal, bladder and prostate cancer. As a researcher, he has over 15 peer-reviewed publications.

Based on his prior works, he is continuing his research with patient-derived xenograft models to assess new techniques of molecular ultrasound imaging in order to predict renal tumor aggressivity and response to targeted therapies.

 

Ashish Kamat

Ashish Kamat

MD - United States

Dr. Ashish M. Kamat is an Associate Professor and Attending Surgeon in the Department of Urology/Division of Surgery at the MD Anderson Cancer Center in Houston, Texas. He is also the Director of the Urologic Oncology Fellowship Program at the same institute. 

Dr. Kamat is an internationally recognized expert in urologic oncology. He has a special interest in cancers of the bladder and prostate, with an emphasis on organ-sparing therapies, minimally invasive techniques (e.g., robotic surgery), and orthotopic bladder substitution (neobladder). While he is a busy, clinically active surgeon, he maintains an active research portfolio in order to improve the care for patients. In the clinical arena, in concert with efforts to develop novel therapies, Dr. Kamat’s efforts are directed toward identifying predictors of response to therapy, as a first step toward personalized cancer therapeutics. A major focus of his laboratory research is to develop novel therapies for bladder cancer using an approach which encompasses novel use of existing agents, the identification of novel targets and therapies, or a combination of these strategies.

Dr. Kamat has authored numerous editorials and more than 150 publications in prestigious peer-reviewed journals, and serves on the editorial board of Expert Reviews in Anticancer and F1000 Reviews. His basic, translational, and clinical research is funded by peer-reviewed awards including ones from the National Cancer Institute (NCI). He serves as project principal investigator (PI) on the MD Anderson Cancer Center GU (Bladder) SPORE (which stands for Specialized Programs of Research Excellence), which is the only one of its kind in the country. He has served as a member on the NCI Bladder Cancer task force and Grant Review Committees (such as NIH-RO1 study sections), and for various international societies (such as the Dutch Cancer Society and NIH—Singapore). 

Dr. Kamat is listed in ‘Who’s Who in Medicine’ and ‘Best Doctors in America,’ and has received the ‘Compassionate Doctor Award.’ He is active in many cancer support groups, such as the MD Anderson Bladder Support Group (for which he serves as Medical Director), as well as the Bladder WebCafe and Bladder Cancer Advocacy Network (BCAN). 

Dr. Kamat is an active member of the urologic community, and a graduate of the American Urological Association (AUA) Leadership Program. He serves on the Board of Directors for the South Central Section (SCS) of the AUA and is The State Representative (Texas) for Urology.

Manish Patel

Manish Patel

MD, PhD - Australia

Prof. Dr.  Manish Patel is a urological oncologist working at Westmead Hospital, the University of Sydney, and Macquarie University, in Sydney, Australia.

After medical school Prof. Patel completed his master’s degree in Cell Biology followed by a fellowship in Urology from the Royal Australasian College of Surgeons. He completed a Uro-oncology fellowship at Memorial Sloan Kettering Cancer Center, New York, and a doctoral degree in novel therapies for prostate cancer.

Currently Prof. Patel has a special clinical and research interest in bladder and prostate cancer. His research program focuses on quality of life evaluations, oncological outcomes and clinical trials. The research program has received over $5 million in grant income, and generated over 100 peer-reviewed publications, five books and seven book chapters. His research papers have been published extensively in many peer-reviewed journals and he is a regularly invited speaker to international urology meetings.

Prof. Patel is a member of several professional organizations including the Urological Society of Australia and New Zealand, the Royal Australasian College of Surgeons American Urological Association (committee member), the European Association of Urology (EAU), Society International d’Urologie (SIU) and Society of Urologic Oncology (SUO).

 

Infection and Inflammation

Tommaso Cai

Tommaso Cai

MD - Italy

Dr. Tommaso Cai is a Consultant Urologist in the Department of Urology, Santa Chiara Regional Hospital in Italy and Head of the Andrology Centre at the same institution.

Dr. Cai studied medicine at the University of Florence, Italy, where he became a qualified urologist in 2007. In 2016 he completed a postgraduate second-level professional master's programme in andrological surgery at the University of Trieste.

Dr. Cai is Secretary of the Italian Society of Andrology and Chairman of the Italian Society of Andrology guidelines working group. He is a member of the European Section of Infections in Urology and of the European Association of Urology (EAU) Guidelines Working Group on Urological infections. He is a board member of the International Chemotherapy Society Committee on Urological Infections.

He is past Chairman of the Italian Society of Urology study group on urological infections and STDs and was a member of the Italian Society of Urology guidelines working group on urological infections.

Dr. Cai a member of numerous national and international societies and serves as reviewer for many urological and nonurological journals including European Urology, Journal of Urology, Urology, British Journal of Urology International, Journal of Endourology, International Journal of Urology, Current Urology, Journal of Infections, British Medical Journal, Drugs, Clinical Infectious Diseases, Journal of Chemotherapy and the International Journal of Antimicrobials Agents. He is editor of several books of urological interest, such as Prostatitis and its Managements and Antibiotics in Urology.

His scientific activity is documented in more than 200 publications in books and Italian and international journals, addressing issues of urinary tract infections, sexually transmitted diseases, andrology, prostate and bladder cancer, the use of novel technologies and a  phytotherapy approach in urological diseases. His main topics of research are prostatitis and urinary tract infections; pathological and clinical factors in prostatitis patients; antibiotic pharmacology and bacterial resistance; the novel approach to Chlamydia trachomatis infections; andrology and male fertility; STDs.

Dr. Cai is the recipient of  many research grants from national and international companies. He has been involved in several advisory boards focused on urological and andrological diseases.

Curtis Nickel

Curtis Nickel

MD, FRCSC - Canada

Dr. Nickel’s research covers inflammatory, benign prostate and pain diseases of the urinary tract. He has over 550 publications, currently sits on the editorial board of 8 Urology journals, editor of the AUA Update Series, presented in 45 countries, funded by US NIH and Canadian CIHR and was awarded a CIHR Tier I Canada Research Chair (until 2021), AUA Distinguished Contribution Award and SIU Academy Award. He is currently Immediate Past-President of the Canadian Urological Association.

 

Lower Urinary Tract Dysfunction

Márcio Augusto Averbeck

Márcio Augusto Averbeck

MD - Brazil

Dr. Márcio Augusto Averbeck is Head of the Neuro-Urology Unit at Moinhos de Vento Hospital in Porto Alegre, Brazil.

Dr. Averbeck is dedicated to the treatment of lower urinary tract dysfunction (both neurogenic and idiopathic), overactive bladder syndrome (OAB), female stress urinary incontinence and post-prostatectomy urinary incontinence. He pioneered in the development of videourodynamics in Southern Brazil.

He is an active member of the ICS Neuro-Urology Promotion Committee (as of 2012) and is working on educational projects for the Brazilian Urological Society in the Neuro-Urology Department (former chairman 2012/13), in the Women's Urology Department (former chairman 2014/15), and as coordinator of E-Learning (2016/17).

Dr. Averbeck received his medical degree from the Federal University of Pelotas, Brazil. He then completed his residency in General Surgery at Grupo Hospitalar Conceição and his residency in Urology at Federal University of Health Sciences of Porto Alegre, Brazil.

In 2009 he was awarded a scholarship from the European Association of Urology (EAU) European Urology Scholarship Program, and became a Clinical Fellow of the Neuro-Urology Unit in Innsbruck, Austria. In 2011, he obtained his master’s degree in Health Sciences from the Federal University of Health Sciences of Porto Alegre.

Dr. Averbeck is a reviewer of the following indexed medical journals: Neurourology and Urodynamics, The Journal of Urology, The Journal of Sexual Medicine, International Urogynecology Journal, International Brazilian Journal of Urology, International Journal of Urology, Arquivos Brasileiros de Endocrinologia & Metabologia, and Saudi Medical Journal. He is also a member of the editorial board for the journal Advances in Therapy.

Joyce Baard

Joyce Baard

MD - The Netherlands

Dr. Joyce Baard is Consultant Urologist at the Academic Medical Center (AMC) University hospital in Amsterdam, the Netherlands, where she completed her Urology residency. Her medical degree was completed at the University of Groningen, the Netherlands.

Dr. Baard’s main fields of interest are the endourologic treatment of stones and upper tract urothelial tumors. Regarding these tumors, she is especially focused on new imaging and diagnostic techniques in close cooperation with the Biomedical Engineering department of the AMC.

She is an active participant in the Endourology Masterclasses organised by the AMC in collaboration with the Tenon Hospital in Paris. These Masterclasses were started to exchange knowledge and skills with participating colleagues. She is a member of various urological societies including the Société Internationale d’Urologie and the American Urological Association.

Ijeoma N. C. Chibuzo

Ijeoma N. C. Chibuzo

MD - Nigeria

Dr. Ijeoma N. C. Chibuzo is a resident in Urology at the University College Hospital (UCH), Ibadan, Nigeria, West Africa. She was the best resident in the nation in the 2014 Surgery pre – subspecialisation (Part I) examinations, for which she was received the prestigious Oritsejolomi Thomas award. Since she commenced training in Urology at UCH, an uncommon choice for females in her country, she has participated in national and international presentations at urological conferences and has won awards for best paper presentations. These include best paper presentations at the  3rd Symposium on Affordable New Technologies in Urology of the 34th SIU Congress, Glasgow, Scotland; and the Pan African Urological Surgeons' Association Conference held in Accra, Ghana, when she presented on behalf of her team members.

She has a Masters in Surgical Sciences in view. She has publications in peer – reviewed journals. She has participated in international exchange programs that have permitted exposure to variegated experiences and learning opportunities. She is currently working on two fellowship dissertations in urological oncology and urodynamics. She is also interested in renal transplantation and endourology.

Dean Elterman

Dean Elterman

MD - Canada

Dr. Dean S. Elterman is an attending urologic surgeon at the University Health Network and an Assistant Professor of Urology in the Department of Surgery, University of Toronto. He is the Medical Director of the Prostate Cancer Rehabilitation Clinic at Princess Margaret Hospital Cancer Centre and a Clinician Investigator in the Krembil Research Institute at the Toronto Western Hospital.

Dr. Elterman has worked in the areas of men’s health and survivorship at the Iris Cantor Men’s Health Center at New York Presbyterian Hospital/Weill Cornell Medical College and at the University of Toronto.

He completed both his medical degree and residency in Urologic Surgery at the University of Toronto. He went on to complete a two-year fellowship in Voiding Dysfunction, Neuro-Urology, Female Urology and Pelvic Reconstruction at Memorial Sloan-Kettering Cancer Center and New York Presbyterian Hospital/Weill Cornell Medical College in New York City.

Dr. Elterman completed his master’s degree in Clinical Epidemiology and Health Services Research at Weill Cornell Graduate School of Medical Sciences. He is a Fellow of the Royal College of Physicians and Surgeons of Canada.

Dr. Elterman is a member of several professional societies including the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction, the Society of Genitourinary Reconstructive Surgeons, the International Neuromodulation Society, and the International Society of Men’s Health.

Mauro Gacci

Mauro Gacci

MD - Italy

Dr. Mauro Gacci is Medical Director in the Department of Urology at the Univeristy of Florence, with a clinical and research focus on minimally invasive surgery, including robotic surgery for benign and malignant prostatic disease. He obtained his medical degree and residency training from the University of Florence and in 2012 he received  his national teaching qualification as Associate Professor.

Dr. Gacci has authored more than 300 publications and is the recipient of several prizes and awards from international meetings and events. He has authored guidelines on LUTS/BPE for the European Association of Urology (EAU), International Consultation of Urological Diseases (ICUD) and Société International d’Urologie (SIU). He is a reviewer for several urologic and non-urologic journals.

Mauricio Plata

Mauricio Plata

MD - Columbia

Dr. Mauricio Plata, a Urologist with 15 years of experience, is Chief of the Department of Urology at the Fundacion Santa Fe de Bogota-Universidad de los Andes school of medicine.  He is Head of the continence clinic and as a research leader with a masters in clinical epidemiology,  he is one of the most active members in the surgical field at the Department of Urology, with a busy appointment agenda and surgical schedule.  Dr. Plata dedicates most of his practice to female and male pelvic health, urodynamics, and voiding dysfunction.

Past accomplishments include being the former executive secretary of the Colombian urological society,  then Vice-president and now President.  Other academic positions held include Director of evidence- based clinical guidelines, Editor of the Colombian Urologic Journal and director of international relations of the Colombian Urological society. He is also a former director of Urodynamics and pelvic floor section of the Confederación Americana de Urología CAU, and currently a member of the CAU board of directors. Dr. Plata takes part in the editorial committee of  BJUI, Actas Urológicas Españolas, and is a reviewer for the International Urogynecology  Journal and Neurourology and Urodynamics Journal.  

Satoru Takahashi

Satoru Takahashi

MD - Japan

Dr. Satoru Takahashi is Professor and Chairman of the Department of Urology at Nihon University School of Medicine, and Vice Director of the Nihon University Itabashi Hospital in Japan. Previously, he held the position of Assistant Professor, followed by Associate Professor within the Department of Urology at the University of Tokyo.

Dr. Takahashi received his medical degree from Gunma University School of Medicine and his doctorate from the University of Tokyo. He completed his residency in Surgery (Neurosurgery) at Gunma University and Urology residency at the University of Tokyo. He was a postdoctoral research fellow at the Department of Urology, Mayo Clinic, USA.

His research interests include voiding dysfunction (BPH, overactive bladder, female LUTS), urogynecology (pelvic floor reconstruction) and urologic oncology (molecular cancer biology and laparoscopic surgery).

Dr. Takahashi is a member of numerous associations including the American Urological Association (AUA), the European Urological Association (EAU), the International Continence Society (ICS) and the International Urogynecological Association (IUGA).

He is Board of Director of the Japanese Urological Association (JUA), the Japanese Continence Society, the Japanese Association for Cancer Detection and Diagnosis, and the Japanese Clinical Oncology Association.

He is Board of Director (Vice Chairman) of Japanese Society of Female Pelvic Floor Medicine and the Japanese Geriatric Urological Association. He is Councilor of the Japanese Society of Endourology.

 

Pediatrics and Transitional Urology

Erin McNamara

Erin McNamara

MD, MPH - United States

Dr. Erin R. McNamara is a pediatric urologist at Boston Children’s Hospital. She assists in the spina bifida center, performing complex reconstructive cases and helping with transitioning care of adolescent/young adult patients with complex urologic conditions. 

Dr. McNamara completed a six-year Urology residency at Duke University followed by a one-year fellowship in Cancer Survivorship and Reconstructive Urology at the same institution. She then completed a three-year Pediatric Urology fellowship at Boston Children’s Hospital. During that time she obtained her master’s degree in Public Health and completed a Health Services Research fellowship at Harvard. 

While both her clinical and research interests are primarily focused on the spina bifida population, she is also interested in other urologic conditions such as exstrophy, posterior urethral valves, disorders of sex development and complex hypospadias that need to be followed into adulthood. She first became interested in transitional urology during residency and spent her research time in fellowship developing projects to better understand the healthcare needs and utilization in this young adult population.  She has carried out both qualitative and quantitative research studying healthcare transition and has looked at outcomes in surgery using both local and national databases.

Dr. McNamara is passionate about establishing a transition program at her home institution. With her unique training in both adult reconstructive urology and pediatric urology, she is building fruitful collaborations with adult reconstructive providers to ensure her patients receive the care they need to lead productive and healthy lives.  

Madina Ndoye

Madina Ndoye

MD - Senegal

Dr Medina Ndoye is a consultant urologist at Grand Yoff General Hospital, in Senegal. In addition to general urology, her main clinical activities are oriented toward reconstructive urology for children and adults. Previously, she was the chief of the urology department at Ziguinchor Regional Hospital.

Dr Ndoye completed her medical studies at Cheikh Anta Diop de Dakar University in Senegal in 2006. She ranked first in the residency admission exam and trained for five years in urology surgery. She completed fellowships in Endourology and Incontinence Surgery (France) Cancer Epidemiology and Prevention (Maryland, USA), and Pediatric Reconstructive Urology Surgery (Pittsburgh, USA). Dr Ndoye also has a degree in environmental and global health.

As a consultant for UNFPA, WAHA and AMREF, she has participated in many national and international workshops on VVF surgery and training, in addition to participating in international conferences on the topic of urology. She is a member of many scientific societies including the American Urological Association (AUA),  AORTIC and Société Internationale D'Urologie (SIU).

Dr Ndoye has authored several publications. She is a member of several associations including the Association of Female Doctors of Senegal (AFEMS), the Senegalese Association for Family Welfare (ASBEF), and International Planned Parenthood Federation Planning ( IPPF). She is an active advocate of women’s health and empowerment. She is also an member (honor) of the LISCA Senegalese League against Cancer.

Barbara Rampersad

Barbara Rampersad

MBBS, FRCS, FRCS (Paed Surg) - Trinidad and Tobago

Dr. Barbara Rampersad is a paediatric surgeon/urologist practicing in Trinidad and Tobago. She completed her postgraduate training in the United Kingdom in 2004 at Alder Hey and Manchester Children's Hospital and completed fellowships at Westmead Children's Hospital in Sydney and Helsinki Children's hospital in Finland.

Dr. Rampersad is the sole paediatric urologist for the island of 1.4 million people, therefore she sees a variety of conditions. She is also a lecturer at the University of the West Indies; her goal is to train upcoming surgeons in paediatric urology.

Dan Wood

Dan Wood

PhD, FRCS(UROL) - United Kingdom

Mr Dan Wood is a Consultant in Adolescent and Reconstructive Urology at University College London Hospitals. He earned his PhD from St Bartholomew’s Hospital Medical School in 1994.

Dan’s principle surgical interest is in major lower urinary tract function and reconstruction in adolescence, particularly with congenital anomalies. He performs major surgical reconstruction for patients with conditions such as bladder exstrophy, disorders of sex development, and spina bifida. He has expertise in augmentation and substitution cystoplasty, ileal conduit, mitrofanoff channels and genitoplasty, including vaginal reconstruction.

Dan did his research and gained his PhD in 2003 with Professor Chris Fry at UCL, looking at cultured bladder cells and their physiology. He continues to maintain a research interest in cell culture and its application, as well as long- term outcomes in adolescent urology.

He is the clinical lead for paediatric surgery and the acute surgical unit, Editor of the Journal of Paediatric Urology, Chairman of the newly formed Congenital Lifelong Urology Working Group in Europe, Patron of the Mitrofanoff Support Charity and a Trustee of the St Peter’s Trust. He is an alumnus of the NHS Staff College Leadership training programme.

Hadley Wood

Hadley Wood

MD - United States

Dr. Hadley Wood is staff urologist at the Cleveland Clinic  and Assistant Professor at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. She has developed a multidisciplinary clinic for adults with spina bifida and serves as an adult specialty advisor to the Transition Services Group of the Cleveland Clinic’s Children’s Hospital.

Dr. Wood received her undergraduate degree from Duke University and medical degree from Johns Hopkins University School of Medicine. After training at the Cleveland Clinic Glickman Urological and Kidney Institute, she joined the faculty and is currently a member of the Center for Genitourinary Reconstruction.  She has carried out basic science research at the Institute for Molecular Medicine in Oxford, England and the Lerner Research Institute at Cleveland Clinic. 

Her area of subspecialty is genitourinary reconstruction with a focus on adolescents and adults with urological congenital defects. These include older patients with exstrophy spectrum, cloacal anomalies, hypospadias, and myelomeningocele. She also cares for adolescents and adults with congenital neurological disorders that have resulted in urological problems, such as muscular dystrophy and cerebral palsy.

In addition to full time clinical responsibilities and resident teaching, Dr. Wood is continuously involved in clinical research and her work has been published in a number of peer-reviewed journals. She serves as section editor for Urology (Congenitalism) and as a peer reviewer for many other journals. She has written nine book chapters related to her specialty areas and has co-edited a textbook on urological congenitalism.

She has been an active member of several societies, including the AUA, Society of Genitourinary Reconstructive Surgeons, Society of Urodynamics and Female Urology, American College of Surgeons, Society of Women in Urology, Cleveland Clinic Women’s Professional Staff Association, Ohio Urological Association and Alpha Omega Alpha. 

Dr. Wood is involved in mentoring and developing resources for women urologists and surgeons within her institution and nationally, and serves as founding Co-chair of the Northeast Ohio Women in Surgery Group and as president as the Women’s Professional Staff Association at the Cleveland Clinic.

 

Reproductive and Sexual Health

Martin Kathrins

Martin Kathrins

MD - United States

Dr. Kathrins is a male infertility and andrology specialist with interests in the treatment of men with azoospermia, advances in hormone replacement therapy, and medical device innovation. He completed undergraduate studies in biology at the University of Pennsylvania and medical school at Columbia University College of Physicians and Surgeons. He completed a surgical internship and urology residency at the University of Pennsylvania in 2014. He subsequently pursued fellowship training in male infertility and andrology at the University of Illinois at Chicago with Craig Niederberger, MD. He is currently a faculty member in the Division of Urology at Brigham and Women's Hospital in Boston, Massachusetts. 

 

 

Jim Hotaling

Jim Hotaling

MD, MS, FECSM - United States

Dr. Hotaling has significant training in both the clinical aspects of male fertility and genetic epidemiology and he is currently the only fellowship trained male infertility/andrology expert in Utah. He completed a 6-year residency in urology at the University of Washington, elected to pursue a year of sub-specialty training in male infertility with Craig Niederberger at the University of Illinois Chicago. He has a long-term research goal of developing novel genetic markers for male infertility that can be used clinically to diagnose and treat this devastating condition.

He has seen and performed surgery on hundreds of men with male infertility and is an associate editor of Fertility and Sterility, a premier journal in the field that has had significant extramural research funding and has over 25 publications. He obtained an MS in clinical epidemiology in 2010 with a focus on statistical genetics and conducted the first genetic study on erectile dysfunction at the University of Washington.

His prior work on building the male fertility cryopreservation databank at the University of Washington resulted in the creation of the largest US database of men cryopreserving sperm for cancer. While at the University of Illinois Chicago, he initiated studies on the genetics of male infertility. As part of this collaboration, he established a protocol for the collection and banking of DNA and serum and linkage to a de-identified database, gMR, an infertility specific electronic medical record. gMR allows uniform phenotyping and is going to be used by several members of a CDC working group for research collaboration.

Faysal Yafi

Faysal Yafi

MD, FRCSC - United States

Dr. Yafi earned his medical degree from the American University of Beirut, Lebanon in 2005 after completing his undergraduate degree in Biology at the same institution in 2001. He then served his internship in General Surgery in the Department of Surgery at the American University of Beirut in 2006 before transferring to the Mayo Clinic in Rochester, Minnesota where he completed a year of preliminary surgery in the Department of Surgery in 2007. He subsequently completed a two-year research fellowship in the Biology and Therapy of Bladder Cancer in the Division of Urology at McGill University in Montreal, Canada in 2009. He subsequently completed his residency in Urology at McGill University in 2014, receiving the Division of Urology Outstanding Resident/Fellow Teacher of the Year Award in 2014. He is currently in the second year of his fellowship in Andrology at Tulane University, where he also serves as Clinical Instructor of Urology.

Dr. Yafi is a Fellow of the Royal College of Surgeons of Canada (Urology). He has previously served as chairman of the Northeastern Section of the AUA Residents Committee and member of the AUA Residents Committee. He is currently a member of the Sexual Medicine Society of North America Young Clinicians Committee. He has received multiple awards and recognitions, including the first prize essay contest of the Canadian Urological Association. Dr. Yafi has an avid interest in both basic and clinical research, with over 40 peer-reviewed publications and book chapters. His areas of focus include Peyronie’s disease, erectile dysfunction, androgen replacement therapy, prosthetic surgery (inflatable penile prosthesis and artificial urinary sphincter), male infertility, and urethral reconstruction.

 

Stone Disease and Endourology

Sero Andonian

Sero Andonian

MSC, MDCM, FRCS(C) - Canada

After obtaining his Bachelor of Science degree (First Class Honours, Dean’s Honour List) in Anatomy and Cell Biology at McGill University, Dr. Andonian pursued a Master of Science degree at the same university with his thesis entitled “Structure and function of the rat vas deferens”. Dr. Andonian obtained his MDCM degree from McGill University in 2002 and completed Urology residency training at McGill University Health Centre in 2007. In order to further develop his minimally invasive techniques, Dr. Andonian completed a two year Endourology fellowship at the prestigious North Shore-Long Island Jewish Health System, under the supervision of Dr. Louis Kavoussi and Dr. Arthur Smith.

 In July 2009, he was appointed Assistant Professor of Surgery (Urology) at McGill University and has been an Attending Urologist at the McGill University Health Centre. To further develop his pedagogical skills, Dr. Andonian completed Teaching Scholars Program for Educators in Health Sciences in 2011.

 Since his faculty appointment, Dr. Andonian has been active in clinical research, including: teaching minimally invasive procedures for treatment of kidney stones, assessing determinants of fluoroscopy usage during endourologic procedures, and determining whether training on simulators improves endourologic surgical outcomes. In addition to minimally invasive procedures and radiation safety, Dr. Andonian is involved in active clinical research regarding medical management of kidney stones. He has received research grants from the Quebec Urological Association, the Canadian Urological Association Scholarship Fund, the Northeastern AUA Young Investigator Award, and most recently he has been awarded the prestigious Chercheur Boursier Clinicien from Fonds de Recherche Santé Québec for the 2013-2017 period.

 He has published over 70 peer-reviewed manuscripts. In addition, he has authored nine book chapters including two chapters in the Smith’s Textbook of Endourology and the chapter on “Surgical, Radiological, and Endoscopic Anatomy of the Kidney and Ureter” in the 11th edition of Campbell-Walsh Urology. Furthermore, he has produced 11 educational videos in the field of endourology. Dr. Andonian has given plenary lectures and courses at several national and international meetings including the Canadian Urological Association (CUA), American Urological Association (AUA), and Société Internationale d’Urologie (SIU) Annual Meetings. He has won several prizes, including the Everett Reid Teaching Excellence Award in 2011 and the Best Laparoscopic Paper at the World Congress of Endourology in 2008. Recently, he has participated in both CUA’s guidelines on ureteral stones and the SIU’s International Consultation on Stone Disease. Currently, Dr. Andonian is on the CUA Executive Committee and editorial boards of Canadian Urological Association Journal and Videourology: Journal of Endourology.

Vitor Cavadas

Vitor Cavadas

MD - Portugal

Dr. Vitor Cavadas is a consultant in the Department of Urology at Santo António General Hospital, Porto, Portugal, and is Head of the Stone Unit within this department. He is also involved in the pre-graduate teaching of Urology at Abel Salazar Biomedical Sciences Institute in Portugal.

Dr. Cavadas graduated from medical school at the Faculty of Medicine of Porto in Portugal (2002). He completed his general internship at St. John’s Hospital in Porto (2003–2004) followed by his residency in Urology at the Santo António General Hospital, in Porto (2005–2010).

Dr. Cavadas is a member of the Portuguese Association of Urology, the Portuguese Society of Andrology and the European Association of Urology. He has participated in several clinical trials and authored many scientific articles in peer-reviewed journals. He was awarded a research grant by the Portuguese Association of Urology.

 

Ranan Dasgupta

Ranan Dasgupta

MBBChir, MA, MD, MRCS, FRCS(Urol) - United Kingdom

Dr. Ranan DasGupta followed graduation from Cambridge University medical school, with a higher degree in Neuro-urology at Queen Square (UCL, London) and pioneering studies of sacral neuromodulation, medical cannabinoids, intravesical botulinum toxin and use of PDE5 inhibitors in neuropathic sexual dysfunction.

He also sub-specialised in Endourology, for which he is the clinical lead at Imperial College Healthcare (London). Based at the leading tertiary centre in west London, the department offers comprehensive stone management, both surgical and medical, with over two decades of experience in  all treatment options. As the main cancer centre, his interest in upper tract urothelial cancer has been maintained, with studies of upper tract photodynamic therapy presented internationally.

Having published numerous peer-reviewed papers, and contributed to several book chapters (and co-editing a textbook on Urinary Tract Infection), he has also been local Principal Investigator for several national research studies (TISU, PURE, UK ROPE), maintaining his interest in clinical and basic research; he is a reviewer for 5 journals. Selected as an examiner for both undergraduate (MBBS) and postgraduate (FRCS(Urol)) levels, he remains committed to maintenance of educational standards.

Selcuk Guven

Selcuk Guven

MD - Turkey

Selcuk Guven received his medical degree from Erciyes University Medical Faculty in 1998. He was awarded specialist certification in Urology from Selcuk University Meram Medical School (Director Prof. Kilinc) in 2005, where he served as a clinical instructor and subsequently Assistant Professor. As a visiting scholar, he gained experience in andrology with Prof. Kadioglu. From 2007-2008, he worked on laparoscopy training and joined the Turkish Urological Laparoscopy Group (Turkurolap). In 2008-2009, he completed a 4-month fellowship training program in laparoscopy at Klinikum Heilbronn Teaching Hospital under the surveillance of Prof. Rassweiler. He was involved with the CROES Project in 2010 and consulted with Prof. de la Rosette and Prof. Laguna in the Academic Medical Centre as a clinical fellow in laparoscopy and endourology. He became Associate Professor in 2012. He served as an organizing committee member and trainer in national and international urology courses and symposia. Dr. Guven participated as a live surgeon in the symposia and one-to-one training meeting organized by Turkurolap and the Turkish Endourology Society. He has published more than 50 peer-reviewed manuscripts and numerous book articles, abstracts and conference presentations. He has served as an Editorial Board Member of European Medical Journal Urology since 2014 and was appointed Associate Editor of The New Journal of Urology in 2016 and Endourology Bulletin of Turkish Endourological Society in 2017. He is a member of the Turkish Endourological Society Board of Directors, Turkish Proficiency Board of Urology and the General Secretary of the Joint Turkish Board of Urology. Dr Guven's primary interest is in minimally invasive management of urinary tract stone disease and endourology and he is currently working in the Urology Department of Istanbul Medipol University.

Amit Kalpee

Amit Kalpee

MD - South Africa

Dr. Kalpee completed his undergraduate degree at the University of KwaZulu-Natal, Nelson R Mandela school of medicine. He subsequently completed post graduate qualifications in Pretoria Academic Hospital, University of Pretoria and completed his fellowship with the College of Surgery (Urology) in Durban, South Africa at Inkosi Albert Luthuli Central Hospital.

He has always had a keen interest in Endourology and was instrumental in opening the first stone clinic in the country at Inkosi Albert Luthui Central Hospital. He also was responsible as a registrar, of creating and running the first dedicated Stone Unit in the province with a dedicated stone theatre offering ESWL, Ureteroscopy and PCNL.

His post graduate training involved a research fellowship with Professor Olivier Traxer and Professor Andries Hosnek in Paris covering flexible ureteroscopy and supine PCNL. He has completed a Holmium laser enucleation masterclass with Professor Scoffone in Turin, Italy. He was the only South African awarded the International Endourology fellowship in 2012 with Professor Monga at the Cleveland Clinic.

Dr Kalpee is currently a practicing Endourologist in Durban with interest in stone disease and holmium laser enucleation of the prostate. He is proficient in performing ureteroscopy and laser lithotripsy having performed more than five hundred procedures. He is currently also the only surgeon in the country performing supine percutaneous nephrolithotomy, having performed more than one hundred punctures. Dr Kalpee was also the first Urologist in the country to perform Holmium Laser Enucleation of the prostate and is the founding member of the South African Holmium User Group (SAHUG).

Dr Kalpee has presented at several endourology meetings both nationally and internationally, including the Expert in Stone Disease Meetings and the World Congress of Endourology. He is also a keynote speaker for Boston Scientific, Bayer medical and Karl Storz. He is a member of the International Endourology society and the Southern African Endourology Society. His publications include Supine PCNL and demographics of renal calculi patients in Kwazulu-Natal. 

Sanjay Khadgi

Sanjay Khadgi

MD, MS - Nepal

Coming Soon

Athanasios Papatsoris

Athanasios Papatsoris

MD, MSc., PhD, FEBU - Greece

Prof. Athanasios Papatsoris is Assistant Professor of Urology at the 2nd Department of Urology, School of Medicine, Sismanoglio General Hospital in Athens Greece.

Prof. Papatsoris graduated from the University of Patras School of Medicine with an honorary scholarship, and from the same university, earned a master of science degree in Pathobiochemistry with his thesis on benign prostatic hyperplasia (BPH). His doctoral thesis on bladder cancer was completed at the 2nd Department of Urology of Athens University.

He received his urology training in London and Athens, where he was certified as a Urological Surgeon. In London he completed a two-year Endourology fellowship, and in France, a clinical fellowship in Laparoscopy. He served as an honorary consultant in Urology at Royal London Hospital, Barts Health NHS Trust for one year. He obtained his Fellow of the European Board of Urology (FEBU) degree in Athens and has since been an FEBU examiner.

Prof. Papatsoris is an Associate Board member of the EAU Section of Urolithiasis (EULIS) and Secretary of the Hellenic (Greek) Urological Association (HUA). He is a Board member of the EAU Young Academic Urologists (Endourology Group), the European Board of Urology (EBU) National Delegate, the Societé Internationale d'Urologie (SIU) National Delegate, the HUA Section of Endourology – Laparoscopic Surgery and Urotechnology, the Institute of Molecular Medicine and Biomedical Research (IMIBE), and the Hellenic Genito-Urinary Cancer Group (HGUCG).

Prof. Papatsoris has more than 140 publications in PubMed indexed journals and is on the editorial board of 14 urology journals. He has participated as faculty in several international congresses, workshops and intensive courses across Europe, America, Middle East, Asia and Australia.

Daniel Perez-Fentes

Daniel Perez-Fentes

MD, PhD - Spain

Prof Dr. Pérez-Fentes heads the Endourology Unit in the University Hospital Complex of Santiago de Compostela in Santiago de Compostela, Spain. As part of his responsibilities, he organizes several national and international endourology training workshops and courses each year. He also holds the positon of Associate Professor in the School of Medicine at the University of Santiago de Compostela.

Dr. Daniel Pérez-Fentes received his medical degree from the University of Santiago de Compostela in Spain (2002) and continued his education, specializing in urology (2008). He completed his training at the Galdakao-Usansolo Hospital in Vizcaya, Spain, the Azienda Ospedaliera San Luigi di Orbassano in Turin, Italy and the Memorial Sloan-Kettering Cancer Center in New York, USA. He is a Fellow of the European Board of Urology (FEBU) as of 2011. His doctoral thesis was on the functional, systemic and quality of life effects of percutaneous nephrolithotomy (2013).

Dr. Pérez-Fentes lectures on endourology in international and national conferences, as well as performing live surgeries in numerous courses or congresses. He is editor of the book titled “Practical handbook on supine percutaneous nephrolithotomy” and he has authored 30 chapters in urological books and 49 scientific papers. Currently he is directing two doctoral theses on urinary stone management.

Dr. Pérez-Fentes is a member of the European Association of Urology (EAU), the Société Internationale d’Urologie (SIU) and the Spanish National Association of Urology (AEU). He is a member of the Galician Royal Academy of Medicine and Surgery as of 2016.

Satyendra Persaud

Satyendra Persaud

MD - Trinidad

Dr. Persaud completed his medical training at the University of Guyana in 2005. He did his internship and general surgery training at the Queen Elizabeth Hospital in Barbados. He completed his residency in Urology at the San Fernando General Hospital, which is a University of the West Indies teaching hospital. It is also a member of the SIU Academy sub-committee on Stone Disease and Endourology. He also has served as Organizing Secretary of the Caribbean Urological Association for the past 3 years. He has an interest in uro-oncology, urolithiasis and reconstruction. He also enjoys cricket and fishing.

Mohammad Radfar

Mohammad Radfar

MD - Iran

M Hadi Radfar, MD, is Assistant Professor of urology and co-director of fellowship program at National Center of Excellence in Iran, Shahid Labbafinejad Medical Center. He completed his urology residency in 2010 and achieved the first rank in National Board Exam. He then completed a two-year fellowship in advanced Endourology and Urolaparoscopy. He is a member of Innovation and Technology Committee of Société Internationale d’Urologie (SIU). He is also a member of Executive Committee and Board of Directors of Iranian Endourology and Urolaparoscopy Society. In Iranian Urological Association (IUA), he holds the position of deputy chairman of young urologists committee.

Dr. Radfar’s primary surgical, clinical, and research interests include minimally invasive management of stones, laparoscopy of kidney and ureter, and management of bladder cancer. He has published over 40 manuscripts in peer-reviewed literature.

Sabnis Ravindra

Sabnis Ravindra

M.S., M.Ch. (Urology) - India

Dr. Ravindra Sabnis is Chairman of the Department of Urology and consultant urologist at the Muljibhai Patel Urological Hospital (MPUH) in Nadiad, India. In the past, he held the positions of council member, secretary, and president of the Urological Society of India West Zone. He was also Chairman of the Board of Education and a past governing council member of the Urological Society of India. Dr. Sabnis is a recognized teacher and examiner for the National Board of Examinations in New Delhi, India for more than 20 years.

 

He is an active member of several urological societies including the Société Internationale d’Urologie, the World Endourological Society, the American Urological Association, the Urological Association of Asia, the Urological Society of India, and the Nepal Urological Association.

 

Dr. Sabnis has presented over 150 papers in national and international conferences and has received numerous awards for best paper, poster, and video categories. He has also been invited as guest lecturer nationally and in many international conferences. He has participated in more than 50 live surgery workshops in India and abroad.

 

Dr. Sabnis has published over 100 papers in peer-reviewed journals and was co-author of eight book chapters and author of one book. He serves as a reviewer for several journals including the World Journal of Urology, Urology, the British Journal of Urology, the Journal of Endourology, the Indian Journal of Urology, as well as the Journal of Urology.

 

SIU-ERAS Programme Committee

Stephen B. Williams

Stephen B. Williams

MD - United States

Dr. Stephen B. Williams is Associate Professor, Robert Earl Cone Endowed Professorship, Director of Urologic Oncology, Director of Urologic Research and Co-Director for the Department of Surgery Clinical Outcomes Research Program at the University of Texas Medical Branch at Galveston. Dr. Williams completed Urology residency at Harvard Medical School’s Brigham and Women’s Hospital followed by a Society of Urologic Oncology fellowship at the University of Texas MD Anderson Cancer Center. 

Dr. Williams is currently a member of many national societies, which include the American Urological Association, European Association of Urology, Society International Urology, Society of Urologic Oncology and the American Society of Clinical Oncology. He serves on the board for the Society of Robotic Surgery, International Bladder Cancer Network and is chair for the Society International Urology ERAS Initiative. He is currently a reviewer for numerous journals including the Journal of the American Medical Association, Journal of Urology, European Urology, Urology, Urologic Oncology and the BJU (editorial board). His research has been awarded Best Research Award at the 2016 annual AUA meeting and more recently at the 2018 33rd Annual EAU Congress in Copenhagen. He is the author of over 100 peer-reviewed manuscripts and book chapters dedicated to urologic oncology and health services research. 

Dr. Williams has made a significant impact on urology through his seminal research in comparative effectiveness regarding bladder and prostate cancer treatments. His important work has carefully examined costs and outcomes in regards to optimizing current treatments for bladder and prostate cancer. He has previously been invited to present his work at the Institute of Medicine in Washington, DC to help guide health policy decision-making. His research focus is identifying at-risk bladder cancer patients and interventions to improve bladder cancer survival. This research is supported by a Department of Defense office of the Congressionally Directed Medical Research Programs (CDMRP) Peer Reviewed Cancer Research Program (PRCRP) Career Development Award (CA160108). 

 

 

 

 

 

 

Justin Collins

Justin Collins

MD - Belgium

Dr. Collins is the medical director at ORSI Academy in Belgium. Over the last 4 years he has worked as a Urologist and research coordinator at the Karolinska Institutet in Stockholm, Sweden. He graduated from Bristol University England and has completed specialist surgical fellowships at Clinique St Augustine, Bordeaux; Karolinska, Stockholm; USC Keck Medical Los Angeles and Mansoura University Hospital, Egypt. His research interests include telemedicine, efficiency studies, train the trainer course, ERAS protocols and health informatics for patients and surgeons.

Dr. Collins is currently coordinating research work to standardize robotic training curriculums. This work includes integration of novel technologies to help develop an international robotic network with the future potential to enable collaborative telementorship, educational webinars and MDT’s to guide and improve decision making whilst promoting international relationships.

Dr. Collins has published over 80 articles, including several book chapters on robotic surgery technique. His MD thesis findings were highlighted in ‘Best of BAUS’ in 2005 and won 1st prize in ‘Best International Research Paper’ at the World Congress of Endourology in 2004.

He is a board member of several organizations.

 Dr. Collins is a reviewer for several high impact journals including, European Urology, the BJUI, Journal of Endourology and the Journal of Urology. He was also section editor for Current opinions in Urology from 2014-2016.

Hooman Djaladat

Hooman Djaladat

MD, MS - United States

Hooman Djaladat, MD, MS, is an associate professor of clinical urology, at the USC Institute of Urology. Dr. Djaladat went to medical school at Tehran University of Medical Sciences in Tehran, Iran. He was among the top in his class and did urology residency in Sina Hospital, one of the well-known urology centers in Tehran University of Medical Sciences. Before finishing his residency, Dr. Djaladat did a training in endo-uro-oncology in Medway Hospital, affiliated with the University College of London in United Kingdom. In 2004, Dr. Djaladat started his academic career in urology as assistant professor of Urology. From 2007 to 2009, he did his endourology and urolaparoscopy clinical fellowship in Labbafinejad Medical Center, which is one of the most prestigious centers pioneering modern urology in Middle East. Subsequently, he moved to the United States and completed his SUO-accredited urologic oncology fellowship at the Keck School of Medicine of USC in 2012 and immediately joined the USC Institute of Urology. Dr. Djaladat has published more than 75 peer-reviewed articles and book chapters; some of them are the results of impressive surgical clinical trials. He has also been selected as a reviewer to many urology journals. Dr. Djaladat also invented a new Foley catheter for prostatectomy patients, which has been filed with the US Patent and Trade Organization.

James Douglas

James Douglas

MD - United Kingdom

James Douglas is a Uro-oncological surgeon who works as an NHS consultant at University Hospital Southampton. He graduated from Guy’s and St Thomas’ medical school, London, in 2003 before undertaking surgical training and ultimately specializing in Urology. He was awarded the Sir Geoffrey Chisolm gold medal for his MSc in 2010 and was awarded his doctoral thesis, looking at novel in-vitro models and biomarkers for muscle invasive bladder cancer, in 2016. 

He completed his uro-oncology fellowship at Vancouver General Hospital before taking up his post in the UK where his sub-speciality interest is in open and minimally invasive surgery for bladder, kidney and testis cancers.

His research interest are primarily around molecular targets and genomics for bladder cancer.  His doctoral thesis and ongoing collaborations, including active research projects, have led to numerous publications in peer reviewed journals.

Mr. Douglas is an ERAS enthusiast and feels the team approach is essential to reduce the morbidity and mortality of major surgery.

Lucy Fairchild

Lucy Fairchild

RN - United Kingdom

Ms Fairchild is a registered nurse at University Hospital Southampton. She works with the urology department and was instrumental in developing a special service provided to urology patients. This service is a training package which enables patients requiring a trial without catheter post surgery to be discharged earlier than before. With patients leaving earlier more beds are available for either the acutely unwell emergency admissions or for the elective patients thereby reducing the level of elective cancellations due to lack of beds.

Ashish Kamat

Ashish Kamat

MD - United States

Dr. Ashish M. Kamat is an Associate Professor and Attending Surgeon in the Department of Urology/Division of Surgery at the MD Anderson Cancer Center in Houston, Texas. He is also the Director of the Urologic Oncology Fellowship Program at the same institute. 

Dr. Kamat is an internationally recognized expert in urologic oncology. He has a special interest in cancers of the bladder and prostate, with an emphasis on organ-sparing therapies, minimally invasive techniques (e.g., robotic surgery), and orthotopic bladder substitution (neobladder). While he is a busy, clinically active surgeon, he maintains an active research portfolio in order to improve the care for patients. In the clinical arena, in concert with efforts to develop novel therapies, Dr. Kamat’s efforts are directed toward identifying predictors of response to therapy, as a first step toward personalized cancer therapeutics. A major focus of his laboratory research is to develop novel therapies for bladder cancer using an approach which encompasses novel use of existing agents, the identification of novel targets and therapies, or a combination of these strategies.

Dr. Kamat has authored numerous editorials and more than 150 publications in prestigious peer-reviewed journals, and serves on the editorial board of Expert Reviews in Anticancer and F1000 Reviews. His basic, translational, and clinical research is funded by peer-reviewed awards including ones from the National Cancer Institute (NCI). He serves as project principal investigator (PI) on the MD Anderson Cancer Center GU (Bladder) SPORE (which stands for Specialized Programs of Research Excellence), which is the only one of its kind in the country. He has served as a member on the NCI Bladder Cancer task force and Grant Review Committees (such as NIH-RO1 study sections), and for various international societies (such as the Dutch Cancer Society and NIH—Singapore). 

Dr. Kamat is listed in ‘Who’s Who in Medicine’ and ‘Best Doctors in America,’ and has received the ‘Compassionate Doctor Award.’ He is active in many cancer support groups, such as the MD Anderson Bladder Support Group (for which he serves as Medical Director), as well as the Bladder WebCafe and Bladder Cancer Advocacy Network (BCAN). 

Dr. Kamat is an active member of the urologic community, and a graduate of the American Urological Association (AUA) Leadership Program. He serves on the Board of Directors for the South Central Section (SCS) of the AUA and is The State Representative (Texas) for Urology.

Kelly Mayson

Kelly Mayson

MD - Canada

Kelly Mayson is a Clinical Professor at UBC Department of Anesthesiology, Pharmacology & Therapeutics. She currently is the Director of Quality Assurance for the Department of Anesthesia and Perioperative Care at Vancouver Acute and UBC Hospitals. She has been the NSQIP Anesthesia Champion since 2011 at these two hospitals. She has been actively involved with an Enhanced Recovery After Surgery Program at Vancouver Acute since 2012, and was an anesthesia representative of both the NSQIP ERIN Collaborative and BC ERAS Collaborative. She is currently an advisor for Enhanced Recovery Canada.  Her other areas of interest include neuroanesthesia, postoperative complications, conscious sedation and analgesia training for radiologists, and training physicians in quality improvement projects. 

Julian Smith

Julian Smith

MD - United Kingdom

Dr. Smith graduated from Imperial College in 2002 before carrying out his basic surgical training at the Royal Surrey Hospital followed by two years of clinical research at Guy’s and St Thomas’ hospital in London. The focus of this research was prostate cancer, diagnostic prostate biopsies and robotic radical prostatectomy. In 2009 Julian published his MSc thesis “The evolving role of transperineal template prostate biopsies” before continuing his higher training in Wessex.

Dr. Smith’s principle interests are laparoscopic and open major abdominal and pelvic cancer surgery. He was appointed to University Hospital Southampton (UHS) in 2014 as a bladder and kidney cancer surgeon and has established himself, nationally, as a high volume cystectomist (bladder removal surgeon).

Dr. Smith, also, augments the laparoscopic and open nephrectomy service as well as dovetailing with the prostate team continuing with transperineal biopsies and prostate high dose rate brachytherapy. He continues to enjoy his benign work consisting of vasectomy/peno-scrotology and endoscopic surgery such as transurethral resection of prostate (TURP) to help male urinary symptoms.

Outside the operating room, Dr Smith remains highly patient focused. He has transformed the local Enhanced Recovery Programmes for patients after major urological surgery and has written the national guidelines for the British Association of Urological Surgeons.

 

Trauma and Reconstruction

Benjamin Breyer

Benjamin Breyer

MD - United States

Dr. Breyer graduated from the University of Chicago Pritzker School of Medicine. He attended residency at the University of California San Francisco.  Breyer completed a fellowship in complex male genitourinary reconstruction and trauma surgery under the direction, of Jack W. McAninch, MD.  Breyer was invited to join the faculty in 2011. In 2014, he was named Chief of Urology, San Francisco General Hospital.

Breyer’s clinical interests include complex urethral and penile reconstruction, male incontinence, male fistula, surgical treatment for erectile dysfunction, and transgender surgery. He is expert in both minimally invasive and complex open reconstructive surgery.

Breyer’s primary research interests involve studying the epidemiology of sexual dysfunction, lower urinary tract symptoms, and trauma and reconstruction.   He is NIH supported and has authored or coauthored over 150 articles and book chapters. Breyer is a member of the Trauma and Urinary Reconstructive Network of Surgeons (TURNS - http://turnsresearch.org).

Jessica DeLong

Jessica DeLong

MD - United States

Dr. Jessica DeLong is a urologist in Virginia Beach, Virginia and is affiliated with Chesapeake Regional Healthcare.

Dr. DeLong completed her undergraduate degree in biology and Spanish at the University of Virginia in 2003. She earned her medical degree from Eastern Virginia Medical School in Norfolk, Virginia in 2007 and was appointed to the Alpha Omega Alpha honors society. Both her surgery internship and Urology residency were completed at the Lahey Clinic in Burlington, Massachusetts. She went on to complete a fellowship in Adult and Pediatric Reconstructive Urology at Eastern Virginia Medical School in 2014.

Dr. DeLong specializes in pelvic floor and genitourinary reconstruction, including male urethral stricture, Peyronie’s disease, erectile dysfunction, male and female incontinence, female prolapse and complicated urinary disorders. She is a member of the American Urological Association (AUA), Genitourinary Reconstructive Surgeons (GURS), Société Internationale d’ Urologie (SIU) and Society of Women in Urology (SWIU).

Dr. DeLong has published in several journals and text books. She has presented her research widely, both at national and international levels. She is committed to working in resource-poor settings and has traveled with IVUmed while in training and as a visiting professor. She has worked extensively as an international medical educator (IME) with Physicians for Peace.

Dmitriy Nikolavsky

Dmitriy Nikolavsky

MD - United States

Dr. Dmitriy Nikolavsky earned his medical degree from Wayne State University School of Medicine in 2005 after completing his Bachelor’s degree in Biochemistry at University of Detroit Mercy in 2000.  He completed his internship in General Surgery in 2007 and subsequently his residency in Urology in 2011, both at William Beaumont Hospital in Royal Oak, Michigan.  He went on to train at the University of Colorado as a fellow in genitourinary reconstruction in 2011. He then joined the faculty at SUNY Upstate Medical University in Syracuse, NY with an appointment as Assistant Professor in Urology and Director of Reconstructive Urology in 2012. 

Dr. Nikolavsky runs a busy practice that focuses on reconstructive urology. His clinical interests include urethral reconstruction, fistula, male incontinence and correction of complications of transgender surgery. He holds a wide array of research interests, encompassing both clinical and patient-reported outcomes of urologic reconstruction, and development of novel techniques for urethral and ureteral reconstruction. He is working in collaboration with several centers in the US and worldwide on projects ranging from bench research to clinical outcomes studies.

Dr. Nikolavsky is a member of the Société Internationale d’Urologie (SIU), American Urological Association (AUA), Society of Genitourinary Reconstructive Surgeons (GURS) and International Russian-speaking Urological Society (iRUS). Since 2012, he has served as the Program Director/AUA Liaison for the Russian Language Session at the AUA annual meeting.

Arabind Panda

Arabind Panda

MS, MCh - India

Dr. Panda is Associate Professor of Urology at the Christian Medical College hospital, Vellore, India. He completed his Urological training in 2009 and has been focusing mainly on reconstructive urology and genitourinary trauma.

He has been an associate editor of the Indian Journal of Urology  for the past 5 years. He is particularly interested in reconstructive surgery of the urethra, both male and female; particularly in difficult posterior urethroplasty apart from vesicovaginal and rectourethral fistulas. He was awarded the 2014 AUA/IAUA Chakrobortty fellowship  by the American Urological Association and the 2013 the Klinikum Luneburg German Fellowship 2013.

He is closely involved in mentorship and training of urological residents and has more than 13 publications.

Jack Zuckerman

Jack Zuckerman

MD - United States

Dr. Zuckerman attended medical school at Wake Forest University School of Medicine.  He completed an internship in General Surgery at the Naval Medical Center in San Diego and then went on to complete Urology residency at Eastern Virginia Medical School in Norfolk, Virginia.  He finished his training at EVMS with a fellowship in genitourinary reconstructive surgery.  He recently returned to California and is faculty at the Naval Medical Center in San Diego.

 Dr. Zuckerman’’s research interests are primarily focused on male reconstruction, including ongoing prospective randomized controlled trials, basic science animal models and large clinical databases.  While his focus is on urologic reconstruction he has published on a variety of other urologic topics, including oncology and general urology.

 

Uro-oncology - Kidney

Joseph Ischia

Joseph Ischia

MD - Australia

Dr. Joseph Ischia is a urologist with a special interest in urologic oncology. He completed a two- year clinical and research post-doctoral uro-oncology fellowship at the Vancouver Prostate Centre in Vancouver, Canada where he performed research focusing on targeting the insulin-like growth factor binding proteins with a novel antisense in the treatment of advanced castration - and enzalutamide-resistant prostate cancer with Professor Martin Gleave. Joseph graduated medicine from Melbourne University in 1998 where he also completed his PhD (2012) investigating the role of a neuroendocrine growth factor (gastrin-releasing peptide) and its precursor in the growth of renal cell cancer. As well as his clinical duties, he continues to be heavily involved in research at the University of Melbourne, Austin Hospital where he is currently studying the protective role of zinc in renal ischaemia and prostate cancer progression.

Jose Karam

Jose Karam

MD, FACS - United States

Dr. Karam is an Assistant Professor of Urology at MD Anderson Cancer Center. He is certified by the American Board of Urology, and provides surgical care for patients with renal, testicular and adrenal tumors. He performs open, laparoscopic, and robotic surgery, with a special interest in surgery for locally advanced and locally recurrent disease.

Dr. Karam earned his medical degree with Distinction from the American University of Beirut. He completed Urology residency at UT Southwestern Medical Center, followed by a Urologic Oncology Fellowship at MD Anderson Cancer Center.

Dr. Karam’s primary clinical and research interest is renal cell carcinoma. He has authored more than 130 articles in urologic oncology. He serves as a reviewer for over 20 journals, and is an Editorial Board member of BJU International, Associate Section Editor for Annals of Surgical Oncology, Section Editor for BMC Urology, and Associate Editor for Frontiers in Oncology.

Dr. Karam is fluent in English, Spanish, Arabic and French and presents in these languages as needed.

Tobias Klatte

Tobias Klatte

MD - Austria

Tobias Klatte is Associate Professor of urology at the Medical University of Vienna, Austria. He obtained his medical and doctoral degree at the University of Magdeburg (Germany). He completed a research fellowship in urologic oncology at the University of California-Los Angeles before starting clinical training at the Medical University of Vienna. He is now a faculty member of the department. His main clinical interests are surgical oncology and endourology. His research is focused on kidney cancer and bladder cancer. In 2012, he completed his habilitation on prognostic factors in renal cell carcinoma. He has been recognized for his research activities by national and international awards.

Pilar Laguna

Pilar Laguna

MD - Turkey

Doctor Pilar Laguna qualified in medicine from the Autonomous University of Barcelona, Spain, in 1979. Following completion of her training as urologist she joined the medical staff at Hospital del Sagrado Corazon and later Fundacion Puigvert in Barcelona. She was appointed chairman at the Hospital Gral La Mancha Centro in Alcazar de San Juan in 1995 and moved in 2000 to the Netherlands. At present she holds the position of professor in Urological Oncology at the Amsterdam UMC University Hospital and professor in Urological Oncology at Istanbul Medipol University. 

Doctor Pilar Laguna is chairman of the EAU guidelines committee on testicular cancer. She is past chairperson of the Ablative working party of the EAU Section of Uro-Technology (ESUT). Her main interest is Renal Cancer and she is one of the pioneers of developing programs on renal cryosurgery in Europe. She has been appointed chairperson of the Renal Mass study that is conducted by the Clinical Research Office of the Endourological Society (CROES). She is a member of the Expert team of the SIU Academy of the Société International d’Urologie (SIU). Within the Editorial Board of the World Journal of Urology she holds the position of Associate Editor on behalf of SIU

Doctor Pilar Laguna has published over 300 peer-reviewed articles in the field of urology, with special focus on minimally invasive therapy, oncological urology and endourology. She co-editor of a book on testicular cancer and has published over 20 book-chapters

 

Uro-oncology - Prostate

Brian Chapin

Brian Chapin

MD - United States

Dr. Brian Chapin is an Assistant Professor in the Department of Urology at The University of Texas MD Anderson Cancer Center.  He provides complete surgical care for men and women diagnosed with urologic malignancies. He performs open surgery and minimally invasive/robotic surgery, for patients with prostate, kidney, bladder and testis cancers.  His major clinical focus is on the treatment of high risk- localized, locally advanced and metastatic prostate cancers. He has active clinical research protocols developing the integration of surgical, radiation and medical therapies in the treatment of advanced prostate cancer.  Dr. Chapin is involved with the basic science/translational research program at M.D Anderson, which is attempting to identify the immunologic changes that occur with surgical and systemic therapy treatments in advanced prostate cancer and how these changes may be exploited with use of newer immune modulating therapies.  Using a comprehensive multimodality approach to this disease, Dr. Chapin’s goal is to ease suffering and prolong survival in men with advanced prostate cancer.      

Mohamed Jalloh

Mohamed Jalloh

MD - Senegal

Dr. Mohamed Jalloh is a urologist trained in Senegal (West Africa) and working as a consultant urologist at the Hôpital General de Grand Yoff, Dakar and coordinating the department of Medical Information.

He has expertise in the treatment of urological cancers and research on prostate cancer in men of African descent. He contributed to running an NIH funded research project on prostate cancer under Dr. Serigne Gueye co-PI in collaboration with Dr. Timothy Rebbeck co-PI from University of Harvard. This research focused on a better understanding of clinical and molecular epidemiology of prostate cancer in Senegalese men with an emphasis on developing research infrastructure. The research was further enlarged in a consortium – the Men of African Descent Carcinoma of the Prostate (MADCaP).

In 2013, he completed a UCSF/SIU post-doctoral scholarship training in Urologic Oncology at the University of California San Francisco under Dr. Peter R. Carroll, MD and published peer reviewed papers on prostate cancer.

Dr. Jalloh is the chair of the Developing World Sub-committee of the SIU Multimedia Learning Committee (MLC) since 2015.

In 2015, he completed a Master of Public Health: Management and Control of health programme at the University Alioune Diop of Bambey, Senegal. He is a part time lecturer in urology at the University Saint Christopher of Dakar and in public health at the University Alioune Diop of Bambey. Dr. Mohamed Jalloh is currently an investigator in a NIH/NCI U01 grant funded to this consortium to study the genetics of prostate cancer in Sub Saharan Africa.

Lukman Hakim

Lukman Hakim

MD, Sp.U, MARS.,PhD - Indonesia

Dr. Lukam Hakim is currently a urologist at the Department of Urology, Airlangga University in Surabaya, Indonesia. In addition to his primary responsibility as a clinician focusing on uro-oncology and functional urology, he is head of the urology clinical training programme. He is currently the Vice-chair of the Advisory Board for the Faculty of Medicine.

Dr. Hakim received his clinical training in urology and earned a master’s degree in Hospital Administration from Airlangga University. He was granted a doctoral degree from KU Leuven in Belgium in 2015 under the supervision of Dirk De Ridder. Having a strong interest in the field of urology, Dr. Hakim continued with several clinical fellowships in Uro-oncology and Functional Urology between 2010 and 2015.

In the preclinical setting, Dr. Hakim is strongly focused on the application of stem cells in the treatment of urological disorders. He is currently a member of Airlangga University Stem Cell Research and Development and leads several projects on this research.

Dr. Hakim is a member of several associations including the European Association of Urology (EAU), the Societé Internationale d’Urologie (SIU), the American Urological Association (AUA), Indonesian Urological Association (IAUI), Indonesian Society of Uro-oncology (ISUO) and International Society of Stem Cell Research (ISSCR). Within the Indonesian urological community,
Dr. Hakim was the immediate Past-secretary general, and within the Asia-Pacific community, he is currently an executive board member of Asia Pacific Society of Uro-oncology (APSU) and Asia Pacific Prostate Society (APPS) as of 2017.

Dr. Hakim has published several articles related to clinical urology and stem cell application. He is also active in peer-reviewed journals including  BJUI, the Journal of Urology, Urologia Internationalis, Indonesian Journal of Urology, Journal of Medical Case Reports, BMC Urology, Journal of Men’s Health and Urological Science.

Markus Hohenfellner

Markus Hohenfellner

MD, PhD - Germany

Dr. Marcus Hohenfellner is Professor and Medical Director at the Department of Urology, University of Heidelberg, Germany. He is a board-certified Urologist.

Dr. Hohenfellner has a strong interest in cancer surgery of the kidney, retroperitoneum and small pelvis; minimally invasive urology, Da Vinci robotic surgery, reconstructive bladder replacement and ultra-radical cancer surgery.

He received training in general surgery at the Department of Surgery, and nephrology and basic research at the Department of Physiology, University of Munich. He completed his residency within the Department of Urology and Pediatric Urology, and the Department of Urology, at the University of Witten/Herdecke, Klinikum Barmen, Wuppertal. He completed a fellowship in Urology at University of California, San Franscico.

Dr. Hohenfellner is a member of several national and international urological societies including the German Urological Association (DGU), the European Association of Urology (EAU), the American Urological Association (AUA), the Austrian Urological Association (ÖGU), the Urologic Research Society and the German Transplantation Society.

He has authored more than 100 scientific papers and over 25 book chapters. He has more than 100 published contributions to scientific meetings in addition to two urological science textbooks.

Dr. Hohenfellner is the recipient of numerous awards including the Miley B. Wesson Resident Essay Contest, Western Section, American Urological Association; Forum Urodynamicum Prize, Forum Urodynamicum;  Jack Lapides Essay Contest (Grand Prize Award); Maximilian-Nitze Prize, German Association of Urology; EAU Thesis Award, European Association of Urology; and the C.E. Alken Prize.

Tilman Todenhöfer

Tilman Todenhöfer

MD - Germany

Tilman Todenhöfer is a urologist at the department of Urology of the Eberhard-Karls-University Tuebingen, Germany (Chairman: A. Stenzl). He has completed a postdoctoral research fellowship at the Vancouver Prostate Centre, Canada. His main fields of interest are circulating biomarkers in advanced prostate and bladder cancer, urine markers for detection of bladder cancer and the inhibition of metabolic pathways for treatment of advanced urothelial carcinoma. He has published more than 80 articles and has received various awards including the Alken Prize, the John-Blandy Prize, the CUA/CUOG research award and the German prostate cancer research award

Shancheng Ren

Shancheng Ren

MD - China

Dr. Shancheng Ren is a Chinese army doctor who completed his medical training and got a phD degree at the Second Military Medical University in 2009. He was sponsored by China Scholarship Council to University of California, San Francisco and trained as joint PhD student from 2008 to 2010. He is now associate professor in Urology at Shanghai Changhai Hospital. His clinical interest is robotic-assisted radical prostatectomy and research interest is the early diagnosis biomarkers for prostate cancer. He enjoys traveling during his free time.

Stephen Williams

Stephen Williams

MD - United States

Dr. Stephen B. Williams is Assistant Professor, Tenure-Track in Urology, Robert Earl Cone Endowed Professorship, Director of Urologic Oncology, Director of Urologic Research and Co-Director for the Department of Surgery Clinical Outcomes Research Program at the University of Texas Medical Branch at Galveston. Dr. Williams completed Urology residency at Harvard Medical School’s Brigham and Women’s Hospital followed by a Society of Urologic Oncology fellowship at the University of Texas MD Anderson Cancer Center. Dr. Williams is currently a member of many national societies, which include the American Urological Association, Société Internationale d’Urologie, Society of Urologic Oncology and the American Society of Clinical Oncology. He is currently a reviewer for numerous journals including the Journal of the American Medical Association, Journal of Urology, European Urology, Urology, Urologic Oncology and the BJU. He is the prior recipient of the American Urological Association (AUA) Gerald P. Murphy Scholar Award and his research has been awarded first prize for clinical research by the New England Section of the AUA and more recently Best Research Award at the 2016 annual AUA meeting. He is the author of over 100 peer-reviewed manuscripts and book chapters dedicated to urologic oncology and health services research.

 

Dr. Williams has made a significant impact on urology through his seminal research in comparative effectiveness regarding prostate cancer treatments. His important work has carefully examined cost effectiveness and outcomes regarding optimizing current treatments for prostate cancer. Most recently, his work has examined the overutilization of treatments in men with low risk prostate cancer and is currently discerning predictors for this overutilization. He has previously been invited to present his work at the Institute of Medicine in Washington, DC to help guide health policy decision-making. He has extended his prior health services research experience to identifying at-risk bladder cancer patients and interventions to improve bladder cancer survival. This research is supported by the Institute for Translational Sciences at the University of Texas Medical Branch, Clinical and Translational Science Award Mentored Career Development (KL2) Award (KL2TR001441) from the National Center for Advancing Translational Sciences and the National Institutes of Health NIH.

 

Uro-oncology - Testis and Penile

Fernando Secin

Fernando Secin

MD, PhD - Argentina

Fernando P. Secin, MD, PhD, is a Urologist Oncologist trained at Memorial Sloan Kettering Cancer Center, NY, USA. He currently works at CEMIC University Hospital and San Lazaro Foundation in Buenos Aires, Argentina. Dr. Secin is an Assistant Professor of Urology at the University of Buenos Aires School of Medicine and at CEMIC University Hospital.

Steve Riggs

Steve Riggs

MD - United States

Dr. Steve Riggs is currently an Associate Professor within the Division of Urology, Surgical Care Division and Levine Cancer Institute in Charlotte, NC. He completed his Oncology fellowship in 2008 at the University of California Los Angles Medical Center. Following this, he accepted an appointment to the Department of Urology, Eastern Virginia Medical Center before relocating to Charlotte. He has an active clinical practice in Urologic Oncology that includes a strong interest in writing and conducting clinical trials. He also has an avid interest in clinical and collaborative translational research. He is director of the institutes’ Cancer conferences, Urologic Oncology fellowship and site director for the Urology resident training that occurs in Charlotte. He has authored or co-authored multiple peer-reviewed manuscripts, editorials and invited articles in addition to serving in local and national leadership roles within the field of Urologic Oncology.